YMAB Y-mAbs Therapeutics Inc: Net Sales Margin

Brandmark of ymabs.com (YMAB)

The loyalty of Y-mAbs Therapeutics (YMAB) scientists is based on a drive to defeat childhood cancer, yet the net profit per unit of revenue demonstrates the volatility of these processes. The value of -26.00 reflects the latest metric value. Stability is guaranteed by insurance coverage for critical pathologies regardless of crises, while the absence of therapeutic analogs allows the company to exercise significant pricing power to set the highest possible treatment costs.

ymabs.com (YMAB) Company Sales Margin: for the period 07/04/2022 - 09/27/2025

YmAbs - analytical breakdowns and key metrics (YMAB)

- share price and expert price forecast:
Summary company analytics:Y-mAbs Corp - YMAB
Finished products of Y-mAbs Therapeutics Inc

Holding exclusive patent rights for rare oncology treatments, Y-mAbs Therapeutics (YMAB) is shielded from generic competition, which directly impacts monetization efficiency. An analysis of the net profit margin chart allows for an assessment of the profit share per dollar of revenue, revealing the business's actual resilience and the company's financial cushion even under pessimistic market scenarios.

Analysis of competing companies

ONC: Net Sales Margin|Net Margin Halozyme Inc. (HALO)|Net Margin RevMed|Net Return on Sales AAPG (Ascentage Pharma Group)|Net Sales Margin CGON|UroGen Pharma - Net Return on Sales|Bicara Therapeutics - Return on Sales by Net Profit|Net Sales Margin Personalis Inc PSNL|Erasca Oncology - Net Sales Margin|Net Profit Rate DCTH (Delcath Corp)|aurabiosciences.com (AURA) - Net Margin|Candel Therapeutics Inc. - Net Profit Rate|Net Margin Accuray Inc.|Net Margin SELLAS Life Sciences Group SLS|Net Sales Margin ACTU|CTOR - Net Margin|Net Sales Margin HURA (TuHURA Biosciences, Inc.)|Net Profit Rate TARA|FATE: Return on Sales by Net Profit|WHWK (aadibio.com) - Net Return on Sales|TCRX (TScan Therapeutics, Inc.) - Return on Sales by Net Profit|Net Margin Champions Oncology Corp (CSBR)|XBIT (XBiotech Inc.) - Net Sales Margin|CVM (CEL-SCI Corporation) - Company Net Profitability|Net Sales Margin OSTX|Net Sales Margin Radiopharm Theranostics Ltd (RADX)|Net Sales Margin ARTV (Artiva Biotherapeutics)|Net Sales Margin Adlai Nortye Ltd. ANL|Veru Inc - Net Sales Margin|Company Sales Margin Tempest Therapeutics TPST|XLO: Net Sales Margin|Enochian BioSciences (RENB) - Net Sales Margin|Return on Sales by Net Profit MURA|Kairos Pharma Ltd - Net Profit Margin|Net Sales Margin OKUR|CytoMed Therapeutics Limited (GDTC) - Net Profitability Margin|Net Sales Margin CRIS (Curis, Inc.)|APLM: Net Return on Sales|Tharimmune Corporation - Net Sales Margin|ADVB: Net Margin|GNPX: Net Sales Margin|CLDI (Calidi Biotherapeutics Inc.) - Net Margin|Net Margin Sunshine Biopharma, Inc.|Net Sales Margin xeneticbio.com|Net Margin Salarius (SLRX)|Return on Sales by Net Profit Purple Biotech PPBT|Net Margin American Oncology Network, Inc. AONC|BeiGene, Ltd. (BGNE) - Net Margin|Checkpoint Therapeutics Inc. - Net Sales Margin|Net Profit Rate ELEV (Elevation Oncology)|ICAD (iCAD Corp) - Return on Sales by Net Profit|Ikena Oncology, Inc. - Net Profit Rate|Return on Sales by Net Profit NTBL|VIRX: Net Profit Rate|Net Margin MorphoSys Corporation (MOR)|NAYA - Net Margin|Net Sales Margin AAPGV (Ascentage)